1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014

Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014" provides data on the Rheumatoid Arthritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Rheumatoid Arthritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Rheumatoid Arthritis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
Rheumatoid Arthritis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Rheumatoid Arthritis to Immunology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Rheumatoid Arthritis to Immunology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Rheumatoid Arthritis 25
Subjects Recruited Over a Period of Time 39
Clinical Trials by Sponsor Type 40
Prominent Sponsors 41
Top Companies Participating in Rheumatoid Arthritis Therapeutics Clinical Trials 42
Prominent Drugs 43
Latest Clinical Trials News on Rheumatoid Arthritis 44
Oct 23, 2014: ABLYNX'S ANTI-IL-6R Nanobody Partnered With Abbvie Demonstrates A Bioavailability Of More Than 80% After Subcutaneous Injection 44
Sep 29, 2014: Compugen Announces Presentations of Results for CGEN-15001 Supporting Immune Tolerance Induction 44
Sep 23, 2014: EPIRUS Announces Positive 58 Week Follow up Data for BOW015 for Treatment of Rheumatoid Arthritis 45
Sep 18, 2014: Galapagos reports high participation rate in long term extension study with GLPG0634 in RA patients 45
Sep 09, 2014: Biotest completes recruitment in Phase IIb study (TREAT 2b) of Tregalizumab (BT-061) in patients with rheumatoid arthritis 46
Sep 03, 2014: Protalex Announces Acceptance of Abstract Highlighting Findings from U.S. Phase 1(b) Trial of PRTX-100 in Active Rheumatoid Arthritis Patients at the 2014 American College of Rheumatology Annual Meeting 47
Aug 18, 2014: Initiation of Phase 3 Trial of CHS-0214 (Investigational Etanercept Biosimilar) in Japan (RApsody) 47
Aug 14, 2014: Coherus Announces CHS-1420 (Investigational Adalimumab Biosimilar) Meets Primary Endpoint in Pivotal Pharmacokinetic Clinical Study 47
Aug 06, 2014: New Data Shows High Efficacy for Can-Fite's CF101 in Rheumatoid Arthritis and Psoriasis Patients 48
Aug 05, 2014: Novimmune Reports Successful Completion of Phase I trial for NI-0101 48
Clinical Trial Profiles 49
Clinical Trial Overview of Top Companies 49
F. Hoffmann-La Roche Ltd. 49
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 49
Pfizer Inc. 68
Clinical Trial Overview of Pfizer Inc. 68
AbbVie Inc. 80
Clinical Trial Overview of AbbVie Inc. 80
Bristol-Myers Squibb Company 87
Clinical Trial Overview of Bristol-Myers Squibb Company 87
AstraZeneca PLC 92
Clinical Trial Overview of AstraZeneca PLC 92
Johnson and Johnson 97
Clinical Trial Overview of Johnson and Johnson 97
C. H. Boehringer Sohn AG and Co. KG 102
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 102
Amgen Inc. 106
Clinical Trial Overview of Amgen Inc. 106
Merck and Co., Inc. 109
Clinical Trial Overview of Merck and Co., Inc. 109
UCB S.A. 113
Clinical Trial Overview of UCB S.A. 113
Clinical Trial Overview of Top Institutes / Government 117
National Institute of Arthritis and Musculoskeletal and Skin Diseases 117
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 117
Academic Medical Center 118
Clinical Trial Overview of Academic Medical Center 118
Osaka City University 120
Clinical Trial Overview of Osaka City University 120
University of Occupational and Environmental Health, Japan 121
Clinical Trial Overview of University of Occupational and Environmental Health, Japan 121
University of Leeds 122
Clinical Trial Overview of University of Leeds 122
Leiden University Medical Center 123
Clinical Trial Overview of Leiden University Medical Center 123
University of California, Los Angeles 124
Clinical Trial Overview of University of California, Los Angeles 124
Department of Health, UK 125
Clinical Trial Overview of Department of Health, UK 125
Saitama Medical University 126
Clinical Trial Overview of Saitama Medical University 126
Tabriz University of Medical Sciences 127
Clinical Trial Overview of Tabriz University of Medical Sciences 127
Five Key Clinical Profiles 128
Appendix 186
Abbreviations 186
Definitions 186
Research Methodology 187
Secondary Research 187
About GlobalData 188
Contact Us 188
Disclaimer 188
Source 188

List of Tables

Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Rheumatoid Arthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Rheumatoid Arthritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Rheumatoid Arthritis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Rheumatoid Arthritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Rheumatoid Arthritis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Rheumatoid Arthritis to Immunology Clinical Trials, G7 Countries (%), 2014* 15
Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Rheumatoid Arthritis to Immunology Clinical Trials, E7 Countries (%), 2014* 18
Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Rheumatoid Arthritis Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Rheumatoid Arthritis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Rheumatoid Arthritis Therapeutics, Global, Terminated Clinical Trials, 2014* 29
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 39
Rheumatoid Arthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 40
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 41
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 42
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 43
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 49
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 68
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014* 80
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 87
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 92
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 97
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2014* 102
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 106
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 109
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014* 113
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014* 117
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014* 118
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka City University, 2014* 120
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Occupational and Environmental Health, Japan, 2014* 121
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leeds, 2014* 122
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014* 123
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014* 124
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2014* 125
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014* 126
Rheumatoid Arthritis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University of Medical Sciences, 2014* 127

List of Figures

Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Rheumatoid Arthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Rheumatoid Arthritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Rheumatoid Arthritis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Rheumatoid Arthritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Rheumatoid Arthritis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Rheumatoid Arthritis to Immunology Clinical Trials, G7 Countries (%), 2014* 15
Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Rheumatoid Arthritis to Immunology Clinical Trials, E7 Countries (%), 2014* 18
Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 39
Rheumatoid Arthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 40
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 41
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 42
Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 43
GlobalData Methodology 187

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026

Epiomic Epidemiology Series: Rheumatoid Arthritis Forecast in 17 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Rheumatoid Arthritis in 17 Major Markets Rheumatoid arthritis (RA) is classified as an autoimmune disease and occurs when the immune ...

Epiomic Epidemiology Series: Lower Back Pain and Sciatica Forecast in 9 Major Markets 2016-2026

Epiomic Epidemiology Series: Lower Back Pain and Sciatica Forecast in 9 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Lower Back Pain and Sciatica in 9 Major Markets Low back pain (LBP) is defined as experiencing musculoskeletal pain, muscle tension, ...

Epiomic Epidemiology Series: Osteoarthritis Forecast in 9 Major Markets 2016-2026

Epiomic Epidemiology Series: Osteoarthritis Forecast in 9 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Osteoarthritis in 9 Major Markets Osteoarthritis (OA), also known as degenerative joint disease / degenerative arthritis, is an inflammation ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.